How do we implement ANNEXXa-I into our Clinical Practice?

November 30, 2023

For acute care physicians, anticoagulated patients presenting with intracranial hemorrhage (ICH) is an incredibly challenging clinical scenario. ANNEXa-I is a randomized, controlled, clinical trial which provides clinicians with important information on appropriate reversal of anticoagualtion to optimally care for these patients.

0 Comments

Tweet Share

Real World Evidence for Management of Severe Bleeding in the Anticoagulated Patient: Impact of Specific Reversal Therapy for Intracranial Hemorrhage and Gastrointestinal Bleeding

July 28, 2023

Real World studies can provide the foundational support necessary for clinicians to effectively manage anticoagulated patients with severe, often life-threatening intracranial and gastrointestinal bleeding. While randomized controlled clinical trials have provided the initial data necessary for appropriate use of reversal agents such as andexanet alfa for Factor Xa associated bleeding, broader studies enrolling thousands of patients, many with significant co-morbidities, are extremely valuable to clinicians. New information regarding the randomized controlled trial ANEXXA-I, which was halted due to andexanet alfa efficacy, provides additional information supporting reversal therapy for severe bleeding.

0 Comments

Tweet Share

The Role of Real World Evidence in Driving Clinical Care for Anticoagulated Patients with Life-Threatening Bleeding

March 31, 2023

Experts in Emergency Medicine, Pharmacy, and Neurocritical Care describe the impact of real world evidence on the care of life-threatening bleeding in the anticoagulated patient. While clinical trial data remain the standard for clinicians, real world data provide important additional information on the use of a particular Repletion or Reversal therapy for these patients.

1 Comments

Tweet Share

What Are the Barriers to Success When Implementing Care Pathways for ICH Patients?

July 12, 2022

ICH remains deadly and pathways matter but they aren't always what we need and barriers can be overcome with knowledge.

0 Comments

Tweet Share

How Do We Coordinate Care Within Our Hospitals To Improve Outcomes in Hemorrhagic Stroke Patients?

July 5, 2022

Coordinating the necessary care for hemorrhagic patients is complicated- learn the ropes from experts on the UC Stroke Team. "Smoother, faster better" is the name of the game.

0 Comments

Tweet Share

RSS

1 2 3 4 5 6 7 8 9 10 Next Last

What Is the Clinical Impact of the Genetic Polymorphism Observed with the Effectiveness of some P2Y12 Inhibitors?

August 3, 2021

The association of genetic polymorphisms and P2Y12 inhibitors in regards to efficacy for patients with ischemic stroke or transient ischemic attack (TIA)...

0 Comments

Keys to the Neurologic Exam From a Stroke Neurologist Who Trains Non-Neurologists to Be Stroke Doctors

June 15, 2021

Ever wonder how a world renowned stroke neurologist teaches the stroke exam? Listen in to learn the foundations of the neurologic exam and strategies for...

0 Comments

CT Angiography - What Should the Rest of Us Know?

June 8, 2021

CT Angiography of the head and neck has become a standard in the Emergency Department as part of the initial workup of a patient with a suspected stroke,...

2 Comments

Tips and Tricks for Posterior Circulation Stroke Identification

June 1, 2021

The posterior circulation is the source of controversy and challenges in the management of acute stroke patients. Listen to a neurointensivist and...

0 Comments

“Gaming the Conversation”: What Really Happens in Your Mind When You Are Evaluating a Patient for Acute Stroke Diagnosis and Treatment?

May 25, 2021

Learn what really happens in the mind of a stroke expert during the evaluation of an acute stroke patient. How to avoid pitfalls and how to make sure the...

0 Comments

Previous 1 2 3 4 5 6 7 8 9 10 Next Last

Brian Gibler / Friday, December 4, 2020

/ Categories: ED First Patient Contact, Care Team, EM, Neuro, Nursing, Pharm, Stroke Team, Time From Stroke, 01_< 6 hrs, 02_6-24 hrs, 03_>24 hrs, 04_Unknown, Types Of Content, Podcast, Fibrinolytic Therapy, Care Team, EM, Hosp Med, Neuro, Neurophys, Neurosurg, Stroke Team, Diagnosis, IS, Topics, Controversies, EBM, IV Rx, Standard Care, Treatments, Types of Content, Podcast, Podcast

What Was Missing From the NINDS Trial?

Moderator: Jordan Bonomo, MD, FCCM, FNCS
Other Participants: Opeolu Adeoye, MD, MS FACEP, FAHA

The NINDS trial was the seminal study of IV-tPA in the treatment of acute stroke. Yet controversy still exists around the trial methodology and the interpretation of the data. Was anything missing from NINDS? Does it still resonate nearly 25 years later?

Dr. Opeolu (Ope) Adeoye sits down with Dr. Jordan Bonomo and shares his immense expertise in clinical trialing. As a researcher carrying over $30M in research funding, Dr. Adeoye is an internationally recognized stroke trialist and methodologist. In this podcast, he talks about the challenges of the NINDS trial, what was really well done and what could have been different. “Time critical diagnosis” is the term he wields in this exciting and thought provoking podcast.

24712 Rate this article:

No rating

Please login or register to post comments.

STAY CONNECTED

Let’s expand your stroke education network. Follow us on Twitter to get the latest updates about stroke education and stay up-to-date on hot topics in stroke care.

ABOUT THE STROKE JOURNEY

The Stroke Journey is an initiative developed by The National Stroke Education Center (NSEC) that strives to be the premier source of educational information for the diagnosis and treatment of stroke in the United States. NSEC extends the world-class educational expertise of the University of Cincinnati Department of Emergency Medicine and its partners via a variety of traditional and digital resources. NSEC and The Stroke Journey are dedicated to providing outstanding stroke education with timely material that mirrors the real-time changes in the medical education and stroke care landscape.

OUR PARTNERS

The Stroke Journey is a collaboration between the NSEC, EMCREG-International, and MedEd On The Go. Together we are committed to providing high-quality stroke education for healthcare professionals.

How do we implement ANNEXXa-I into our Clinical Practice?

Real World Evidence for Management of Severe Bleeding in the Anticoagulated Patient: Impact of Specific Reversal Therapy for Intracranial Hemorrhage and Gastrointestinal Bleeding

The Role of Real World Evidence in Driving Clinical Care for Anticoagulated Patients with Life-Threatening Bleeding

What Are the Barriers to Success When Implementing Care Pathways for ICH Patients?

How Do We Coordinate Care Within Our Hospitals To Improve Outcomes in Hemorrhagic Stroke Patients?

Archive

Categories

More Entries

What Was Missing From the NINDS Trial?

Please login or register to post comments.